Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Adjuvant Radiotherapy of Breast Cancer
- Conditions
- Breast Cancer
- Registration Number
- NCT04506476
- Lead Sponsor
- University Hospital Tuebingen
- Brief Summary
This randomized three-arm trial will test the benefit in terms of cancer related fatigue of an activity tracker based exercise training during adjuvant radiotherapy in breast cancer patients.
- Detailed Description
This monocentric, three-arm, randomized, controlled clinical trial evaluates the effect of an activity tracker based exercise program in breast cancer patients on the fatigue syndrome during adjuvant radiotherapy. Quality of Life and the intensity of fatigue will be documented with the fatigue subscale of the FACIT Questionnaire three months after adjuvant radiotherapy.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 201
- Capacity for consent
- Minimum age 18
- Presence of breast cancer
- ECOG 0-2
- Indication for adjuvant radiotherapy of breast cancer after breast-conserving surgery or Ablatio mammae
- Participation in any other interventional study
- Pregnancy
- Contraindication against physical activity/sport and others
- Severe cardiovascular pre-existing conditions (after myocardial infarction, apoplexy in the last 6 months, congestive heart failure NYHA > I°)
- preexisting diseases with are relevantly accompanied by a limited mobility in patients (e.g. paraparesis of the lower limbs)
- ECOG Status 3-4
- prior use of activity trackers
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Evaluation of the impact of an activity tracker based fitness programme on the fatigue syndrome 3 Months after completion of adjuvant radiotherapy of breast cancer This endpoint will be evaluated by the FACIT-F (Functional Assessment of Chronic Illness Therapy-Fatigue) subscale of the FACIT questionnaire (Physical well-being values 0-28, 28 worse outcome; social/family well-being values 0-28, 28 better outcome; emotional well-being values 0-24, 24 worse outcome; functional well being values 0-28, 28 better outcome; additional factors values 0-64, 64 worse outcome
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University Hospital Tübingen, Department of Radiation Oncology
🇩🇪Tübingen, Baden-Württemberg, Germany
University Hospital Tübingen, Department of Radiation Oncology🇩🇪Tübingen, Baden-Württemberg, GermanyDaniel Zips, MD, ProfContact+49 (0) 7071 29-85990ro-info@med.uni-tuebingen.deCihan Gani, MDContact+49 (0)7071 29-82165cihan.gani@med.uni-tuebingen.de